Adcetris
Generic: brentuximab vedotin
Manufacturer: Pfizer · Program: Pfizer Oncology Together
Apply for AssistanceEligibility Criteria
Insurance Requirement
Commercially insured patients; excludes Medicare, Medicaid, TRICARE, VA, state/federal programs
Residency
US resident
Eligible commercially insured patients may pay as little as $0 per treatment, up to $15,000 savings annually. Not for government insurance including Medicare, Medicaid.
Program Information
Processing Time
4–8 weeks
Delivery Method
shipped to patient or physician office
Application Method
Multiple
Reauthorization
Required — annual
Indicated For
classical Hodgkin lymphoma (cHL), systemic anaplastic large cell lymphoma (sALCL), CD30-expressing peripheral T-cell lymphomas (PTCL)
About This Medication
# Pfizer Oncology Together Patient Guide: How to Get Adcetris (brentuximab vedotin) at Low or No Cost Facing a cancer diagnosis is challenging enough without worrying about medication costs. The **Pfizer Oncology Together** program helps **commercially insured patients** access **Adcetris (brentuximab vedotin)**, a targeted therapy for certain lymphomas, by reducing out-of-pocket expenses to **as little as $0 per treatment**, up to **$15,000 in annual savings**.[1][3] ## About Adcetris (brentuximab vedotin) **Adcetris** is an injectable chemotherapy drug that targets CD30-positive cancer cells. It's a **conjugate**—an antibody linked to a toxin—that delivers treatment directly to lymphoma cells while sparing healthy ones, potentially reducing side effects compared to traditional chemotherapy.[1] Adcetris is FDA-approved for several serious conditions, including: - Previously untreated **Stage III/IV classical Hodgkin lymphoma (cHL)** in combination with other drugs like doxorubicin, vinblastine, and dacarbazine. - Previously untreated **systemic anaplastic large cell lymphoma (sALCL)** or other CD30-expressing peripheral T-cell lymphomas (PTCL), combined with cyclophosphamide, doxorubicin, and prednisone. - Relapsed **sALCL** after prior chemotherapy. - **Primary cutaneous anaplastic large cell lymphoma (pcALCL)** or CD30-expressing **mycosis fungoides (MF)** after systemic therapy. - Relapsed or refractory **large B-cell lymphoma (LBCL)** after multiple therapies, in combination with lenalidomide and rituximab.[1] Your doctor prescribes Adcetris based on your specific diagnosis and medical history. It's administered by a healthcare professional, typically every 2-3 weeks via IV infusion.[1] ## Who Qualifies for Pfizer Oncology Together? This program is a **co-pay savings program**, not free medication. It covers copays, coinsurance, and deductibles for eligible patients.[2][3] ### Key Eligibility Requirements - **Commercial insurance** only (private plans from employers or marketplace like Blue Cross, UnitedHealthcare).[1][2] - **No government insurance**: Excludes Medicare, Medicaid, TRICARE, VA benefits, Social Security Disability, or other federal/state programs.[2] - **U.S. resident** with a valid prescription for Adcetris. - Agree to program **terms and conditions**.[2] **Income eligibility**: No strict household income limits (FPL-based thresholds not specified). However, Pfizer verifies financial need during enrollment and may connect you to additional resources if needed.[3][7] | Household Size | Income Threshold | Notes | |---------------|------------------|-------| | Individual | Not specified | Focus on commercial insurance; savings up to $15,000/year. | | Couple | Not specified | Excludes government benefits. | | Family of 3 | Not specified | Program prioritizes copay reduction. | | Family of 4+ | Not specified | Contact program for personalized review. | *Table note: Unlike free drug programs, this co-pay assistance has flexible income review but strict insurance rules.*[1][2][3] ## Insurance Requirements **Must have commercial insurance** covering Adcetris. Government programs are **not eligible**—patients on Medicare Part D, Medicaid, or VA may explore Pfizer RxPathways for other options.[2][8] - **Exclusions**: TRICARE, military health, Social Security benefits.[2] - Pfizer's team verifies your benefits, checks prior authorizations, and appeals denials.[7][9] If uninsured or underinsured, ask your doctor about Pfizer's **Patient Assistance Program** (separate from co-pay savings).[10] ## Step-by-Step Application Process Enrollment is straightforward and can be done **online, by phone, fax, or through your doctor**.[6][7][9] 1. **Discuss with your doctor**: Confirm Adcetris prescription and commercial insurance. Ask them to enroll you via the Provider Portal.[7] 2. **Sign up yourself**: - Visit **PfizerOncologyTogether.com/patient/sign-up**.[2][4] - Select **Adcetris** and complete the form with insurance details. - Or call **1-877-744-5675** (Mon-Fri, 8 AM–8 PM ET).[2][9] 3. **Your doctor enrolls**: - Download the **Adcetris Enrollment Form** from PfizerOncologyTogether.com/hcp/enroll.[5][9] - Fax to 1-877-736-6506 or submit online via Provider Portal.[6][7] 4. **Pfizer reviews**: They verify eligibility, benefits, and issue a **co-pay card** (digital or physical).[6] 5. **Use your card**: Present at infusion center; savings apply automatically (up to $15,000/year).[1][3] **Multiple methods** make it accessible—patient or HCP-led.[7] ## Timeline and Delivery - **Processing**: Benefit verification and approval often within days; full enrollment 1-2 weeks.[6][7] - **Delivery**: Adcetris is **shipped to your doctor's office or infusion center**—never directly to home. Program doesn't handle drug shipping; it covers costs.[1] - **First dose**: Use co-pay card at administration. **Reauthorization required**: Periodic review (e.g., annually or per treatment course) to confirm ongoing eligibility.[program details] ## If Denied or Need Alternatives **Common denial reasons**: Government insurance, max savings reached, or expired eligibility.[2] - **Appeal**: Pfizer's **Field Reimbursement Directors (FRDs)** or **Patient Access Navigators** help with appeals, prior auths, and alternative funding (Mon-Fri support).[1][7] - **Other Pfizer options**: Pfizer RxPathways for uninsured/low-income (proof of income needed; 2-3 weeks processing).[10] - **No biosimilars** available for Adcetris currently.[program details] - **External resources**: NeedyMeds, PAN Foundation, or CancerCare grants. Contact **1-877-744-5675** for personalized navigation.[2] ## Important Disclaimer This guide is for informational purposes only and based on publicly available program details as of latest updates. **Eligibility, benefits, and terms can change**—Pfizer reserves the right to modify/revoke without notice.[2] Always verify with Pfizer Oncology Together at 1-877-744-5675 or PfizerOncologyTogether.com. **Not health insurance**; max $15,000 savings per year. Consult your doctor for medical advice. Not affiliated with Pfizer.[1][2][3] *Word count: ~950*
Program information last verified: March 30, 2026
Ready to apply for Adcetris assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.